Adam Fisher was appointed as a director in the FDA's Office of Pharmaceutical Quality.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Adam Fisher was appointed as a director in the FDA's Office of Pharmaceutical Quality.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Adam Fisher
researcher 0000-0002-1974-2763
Nothing else this week.
Related events
- Cogent Biosciences plans to submit an NDA to the FDA, with Andrew Robbins as President and CEO.
- FDA agreed to reduced sample size for a clinical trial involving X4 Pharmaceuticals.
- Cuong Do leads BioVie as its CEO. BioVie Inc is listed on the NASDAQ exchange and is seeking FDA review for its drug candidate.